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ABSTRACT 
Motivation: Approaches for testing sets of variants, such as a set of 
rare or common variants within a gene or pathway, for association 
with complex traits are important. In particular, set tests allow for 
aggregation of weak signal within a set, can capture interplay among 
variants, and reduce the burden of multiple hypothesis testing. Until 
now, these approaches did not address confounding by family relat-
edness and population structure, a problem that is becoming more 
important as larger data sets are used to increase power.  
Results: We introduce a new approach for set tests that handles 
confounders. Our model is based on the linear mixed model and 
uses two random effects—one to capture the set association signal 
and one to capture confounders. We also introduce a computational 
speedup for two-random-effects models that makes this approach 
feasible even for extremely large cohorts. Using this model with both 
the likelihood ratio test and score test, we find that the former yields 
more power while controlling type I error. Application of our ap-
proach to richly structured GAW14 data demonstrates that our 
method successfully corrects for population structure and family 
relatedness, while application of our method to a 15,000 individual 
Crohn’s disease case-control cohort demonstrates that it additionally 
recovers genes not recoverable by univariate analysis. 
Availability: A Python-based library implementing our approach is 
available at  http://mscompbio.codeplex.com 
Contact:{jennl,lippert,heckerma}@microsoft.com 
1 INTRODUCTION  
Traditional Genome-Wide Association Studies (GWAS) test one 
single nucleotide polymorphism (SNP) at a time for association 
with disease, overlooking interplay between SNPs within a gene or 
pathway, missing weak signal that aggregates in sets of related 
SNPs, and incurring a severe penalty for multiple testing. More 
recently, sets of SNPs have been tested jointly in a gene-set en-
richment style approach (Holden et al, 2008), and also in seeking 
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association between rare variants within a gene and disease (Wu et 
al., 2011; Bansal et al., 2010). As next generation sequencing rap-
idly becomes the norm, these set-based tests, complementary to 
single SNP tests, will become increasingly important. However, 
existing methods for testing sets of SNPs do not handle confound-
ing such as arises when related individuals or those of diverse eth-
nic backgrounds are included in the study. Such confounders, 
when not accounted for, result in loss of power and spurious asso-
ciations (Balding, 2006; A. Price et al., 2010). Yet it is precisely 
these richly structured cohorts which yield the most power for 
discovery of the genetic underpinnings of complex traits. Moreo-
ver, such structure typically presents itself as data cohorts become 
larger and larger to enable the discovery of weak signals.  
In this paper, we introduce a new, powerful and computationally 
efficient likelihood ratio-based set test that accounts for rich con-
founding structure. We demonstrate control of type I error as well 
as improved power over the more traditionally used score test. 
Finally, we demonstrate application of our approach to two real 
GWAS data sets. Both data sets showed evidence of spurious asso-
ciation due to confounders in an uncorrected analysis, while appli-
cation of our set test corrected for confounders and uncovered 
signal not recovered by univariate analysis. Finally, our test is 
extremely computationally efficient owing to development of a 
new linear mixed model algorithm also presented herein, which 
makes possible, for example, set analysis of the 15,000 individual 
Wellcome Trust Case Control Consortium (WTCCC) data.  
Several approaches have been used to jointly test sets of SNPs: 
post hoc, gene-set enrichment in which univariate P values are 
aggregated (Holden et al, 2008), operator-based aggregation such 
as “collapsing” of SNP values (Braun and Buetow, 2011; B. Li and 
Leal, 2008), multivariate regression, typically penalized 
(Schwender et al., 2011; Malo et al., 2008), and variance compo-
nent (also called kernel) models such as a linear mixed models 
(Wu et al., 2011, 2010; Quon et al., 2013).  
Our approach is based on the linear mixed model (LMM) which 
can equivalently be viewed as a multivariate regression.  In partic-
ular, use of a LMM with a specific form of genetic similarity ma-
trix is equivalent to regressing those SNPs used to estimate genetic 
similarity on the phenotype (Hayes et al., 2009; Listgarten et al., 
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2012). If one uses only SNPs to be tested in the similarity matrix as 
in Wu et al., 2010, 2011, then one is effectively performing a mul-
tivariate regression test.  However, by also using SNPs that tag 
confounders in a separate similarity matrix, our model can addi-
tionally correct for confounders, as has been done in a single-SNP 
test GWAS setting (Kang et al., 2010; Yu et al., 2006; Listgarten 
et al., 2012; Lippert et al., 2011). Finally, our approach allows one 
to condition on other causal SNPs, by way of the similarity matrix, 
for increased power, again, as has been done in single-SNP test 
setting (Atwell et al., 2010; Listgarten et al., 2012; Segura et al., 
2012). 
The use of LMMs to correct for confounders in genome-wide as-
sociation studies (GWAS) is now widely accepted, because this 
approach has been shown capable of correcting for several forms 
of genetic relatedness such as population structure and family re-
latedness (Kang et al., 2010; Astle and Balding, 2009; Yu et al., 
2006; A. Price et al., 2010). Independently, the use of LMMs to 
jointly test rare variants has become prevalent (Wu et al., 2010, 
2011). In our new approach, we marry the aforementioned uses of 
LMMs to perform set tests in the presence of confounders within a 
single, robust, and well-defined statistical model.  
Because of the aforementioned equivalence, our approach can also 
be viewed as a form of linear regression with two distinct sets of 
covariates. The first set of covariates consists of SNPs that correct 
for confounders (and other causal SNPs), that is, those which pre-
dict race and relatedness, for example. Inclusion of these SNP 
covariates makes the data for individuals independently and identi-
cally distributed (i.e., knowing the value of these SNPs induces a 
common distribution from which the individuals are drawn). The 
second set of covariates consists of SNPs for a given set of interest, 
such as those SNPs belonging to a gene. We call our approach 
FaST-LMM-Set. 
Computing the likelihood for our model—a LMM with two ran-
dom effects—is, naively, extremely expensive, as it scales cubical-
ly with the number of individuals (e.g., Listgarten et al, 2010). For 
example, on the 15,000 individual WTCCC data set we analyse, 
currently available algorithms would need to compute and store in 
memory genetic similarity matrices of dimension 15,000 × 15,000 
and repeatedly perform cubic operations on them to test just a sin-
gle set of SNPs—a practically infeasible approach. However, ex-
tending our previous work that made LMMs with a single random 
effect linear in the number of individuals (Lippert et al 2011) to the 
two-variance component model needed here, we bypass this com-
putational bottleneck, yielding a new, two-random-effects algo-
rithm which is linear in the number of individuals. This advance 
enables us to analyse data sets which could not otherwise be prac-
tically analysed, such as the 15,000 individual WTCCC cohort 
(The Wellcome Trust Case Control, 2007). As a case in point, 
using the naïve cubic approach to test the gene set IL23R (contain-
ing 14 SNPs) took 13 hours as compared to one minute for our 
new approach (all on a single processor), demonstrating a speedup 
factor of 780 (and significantly less memory usage because the 
genetic similarity matrix need never be computed with our ap-
proach).  
 
 
2 METHODS 
Let 𝑁(𝒗|𝒖; 𝚺) denote a multivariate Normal distribution in 𝒗 with mean 𝒖 
and covariance matrix 𝚺. The log likelihood of a one-variance-component 
linear mixed model in the linear regression view is given by  
LL ≡ log ∫ N (𝒚|𝑿𝜷 +
𝟏
√𝒔
𝑽𝒘; 𝜎𝑒
2𝑰) ⋅ N(𝒘|𝟎; 𝜎𝑔
2𝑰) d𝒘,  
  
where 𝒚 is a 1 × 𝑁 vector of phenotype values for 𝑁 individuals; 𝜷 is the 
set of the fixed effects of the covariates stored in the design matrix 𝑿; 𝑰 is 
an 𝑁 × 𝑁 identity matrix; 𝜎𝑒
2 is the residual variance in the regression; 𝒘 
are the 1 × 𝑁 random effects for the SNPs stored in the design matrix V 
(dimension 𝑁 × 𝑠), and N(𝒘|0; 𝜎𝑔
2𝑰) is the distribution for the weight 
parameters. That is, the random regression weights, 𝒘 are marginalized 
over independent Normal distributions with equal variance 𝜎𝑔
2.  
Equivalently, and more typically, the log likelihood is written with random 
effects marginalized out, 
LL = log N(𝒚|𝑿𝜷; 𝜎𝑒
2𝑰 + 𝜎𝑔
2𝑲), 
where the genetic similarity (called the kernel in some contexts), 𝑲, is 
given by 𝑲= 
𝟏
𝒔
𝑽𝑽𝑻, as is the case, for example, when 𝑲 is the realized 
relationship matrix (RRM) (B. J. Hayes et al, 2009; Lippert et al, 2011). 
Given this equivalence, the SNPs used to estimate genetic similarity (those 
in 𝑽) can be interpreted as a set of covariates in the regression.  
In our model, we partition the random effects into two sets: one set of ran-
dom effects, 𝒘𝑪 (with design matrix 𝑽𝑪), are used to correct for confound-
ers (and condition on causal SNPs) using 𝑠𝑐 SNPs, while the other set, 𝒘𝑺, 
are used to test the 𝑠𝑠 SNPs of interest in the corresponding design matrix, 
𝑽𝑺. The log likelihood (in the linear regression view) is then written 
LL = log ∬ N (𝒚|𝑿𝜷 +
𝑽𝑪
√𝒔𝒄
𝒘𝑪 +  
𝑽𝑺
√𝒔𝒔
𝒘𝑺; 𝜎𝑒
2𝑰) ⋅ N(𝒘𝑪|0; 𝑰) N(𝒘𝑺|0; 𝑰) d𝒘𝑪d𝒘𝑺, 
where each set of random effects has a separate variance (𝜎𝐶
2 and 𝜎𝑆
2). Again, 
we can equivalently write this in the marginalized form, 
𝐿𝐿 = log N (𝒚|𝑿𝜷; 𝜎𝑒
2𝑰 + 
𝜎𝐶
2
𝑠𝑐
𝑽𝑪𝑽𝑪
𝑻 +
𝜎𝑆
2
𝑠𝑠
𝑽𝑺𝑽𝑺
T) . 
For convenience, we re-parameterize this as 
𝐿𝐿 = log N(𝒚|𝑿𝜷; 𝜎𝑒
2𝑰 + 𝜎𝑔
2[(1 − 𝜏)𝑲𝑪 + 𝜏𝑲𝑺]),                   (1) 
   
where now the covariance matrix, 𝑲, has been partitioned into two variance 
components: 
𝑲 ≡ (1 − 𝜏)𝑲𝑪 + 𝜏𝑲𝑺, 
using 𝑲𝑪 ≡
𝟏
𝒔𝒄
𝑽𝑪𝑽𝑪
𝑻 (𝑽𝑪 is of dimension 𝑁 × 𝑠𝑐) to account for confound-
ers, and 𝑲𝑺 ≡
𝟏
𝒔𝒔
𝑽𝑺𝑽𝑺
𝑻 (𝑽𝑺 is of dimension 𝑁 × 𝑠𝑆) to model signal from a 
pre-defined set of SNPs of interest, such as those within a gene. The scalar 
parameter 𝜏 ∈ [0,1] is estimated from the data by, for example, restricted 
maximum likelihood (REML). The null model for our set test is given by 
𝜏 = 0, while the alternative model allows 1≥τ≥0. 
Until lately, estimating the parameters and computing the likelihood of a 
LMM was cubic in the number of individuals. However, we have recently 
shown that when the number of SNPs used to estimate genetic similarity, 𝑠, 
is less than the cohort size, 𝑁, and when genetic similarity matrix, 𝑲, fac-
tors as 𝑽𝑽𝑻 (𝑽 of dimension 𝑁 × 𝑠), then the computations (and memory 
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requirement) become linear in 𝑁 (Lippert et al, 2011). So far this result has 
been applied in the context of correcting for confounders in a univariate 
GWAS with just a single variance component. Originally the 𝑠 SNPs for 
inclusion in 𝑽 were obtained by sampling SNPs genome-wide and relying 
on linkage disequilibrium (Lippert et al, 2011). However, in light of the 
equivalence with linear regression, it became clear that one should choose 
the SNPs with feature selection as one would do in any statistical modelling 
problem (Listgarten et al., 2012, 2013; Lippert, Quon, et al., 2013). For 
example, one can do an uncorrected, univariate scan of the SNPs to select 
those which should be used to correct for confounders (and causal SNPs to 
condition on), and this is precisely the approach we take here, just as in 
(Listgarten et al., 2012; Lippert, Quon, et al., 2013).  
Thus, in our approach, we select 𝑠𝑐 SNPs for 𝑲𝑪 by first sorting all availa-
ble SNPs according to their univariate linear-regression P values (in in-
creasing order), and then evaluate the use of more and more SNPs in order 
until we find an optimal number of SNPs (Listgarten et al., 2012). This 
resulted in 650 and 310 SNPs for the GAW14 and Crohn’s analyses, re-
spectively. Additionally, any SNPs that were being tested (i.e., those in 𝑽𝑺), 
and those within 2 centimorgans, were removed from 𝑽𝑪 so as not to con-
taminate the null model (Listgarten, Lippert, C. M. Kadie et al, 2012). This 
type of approach for correction of confounders in univariate tests has pre-
viously been demonstrated to work well on a broad range of data sets 
(Listgarten, Lippert, C. M. Kadie et al, 2012; Listgarten, Lippert, and 
Heckerman, 2012). However, we note that on some other data sets, we 
found that our original approach (Listgarten et al., 2012) could be sub-
optimal; therefore, we have now moved to a slightly different approach 
(Lippert, Quon, et al., 2013). 
For estimation of variance parameters and computation of the likelihood 
ratio test statistic, we use REML, which is itself a valid likelihood for the 
likelihood ratio test (LRT) and can be computed in the same time and 
memory complexity as the (unrestricted) likelihood. Details on efficient 
parameter estimation are provided in (Lippert et al., 2011). 
When testing sets in an uncorrected manner, that is, without accounting for 
confounders (which we did for comparison purposes), we omitted the por-
tion of the variance which corrected for confounders, 𝑲𝐶 . In particular, we 
set 𝜏 = 1, and tested the significance of 𝜎𝑔
2 with the same LRT described 
next. 
P Value Computation 
We have now fully specified our model for doing set tests when confound-
ers are present. To obtain a P value on the set of SNPs of interest, such as 
those belonging to a gene (i.e., those in 𝑽𝑺), we use an LRT. In particular, 
to test the significance of the set of SNPs of interest, we compare the max-
imum restricted likelihood of the data with and without the set of SNPs of 
interest, that is, the maximum restricted likelihood of the alternative and 
null models. More formally, our null hypothesis is given by 𝐻0: τ=0, while 
our alternative hypothesis is given by 𝐻𝑎: 1 ≥ 𝜏 ≥ 0. 
To obtain calibrated P values, we require an accurate estimate of the distri-
bution of statistics under the null hypothesis. However, obtaining a suffi-
ciently accurate estimate of this distribution is not straight-forward. Stand-
ard software uses a parametric form for this distribution of 0.5𝜒𝑜
2 ∶ 0.5𝜒1
2—
a 50-50 mixture of two 𝜒2 distributions, the first with zero degrees of free-
dom, and the other with one degree of freedom. The former accounts for 
the fact that the tested parameter is on the boundary of the allowed space in 
the null model (Self and Liang, 1987; Dominicus et al., 2006)—that is, to 
account for the fact that 𝜏 = 0 in the null model, and 1 ≥ 𝜏 ≥ 0 in the 
alternative. The necessary regularity conditions for this null distribution to 
hold, include that the outcome variable can be partitioned into a large num-
ber of identically and independently distributed sub-vectors (Greven et al., 
2008)—conditions which are not generally met in our setting because indi-
viduals may be arbitrarily related to one another. It has been shown that 
when the regularity conditions are not met, the 0.5𝜒𝑜
2 ∶ 0.5𝜒1
2 distribution 
yields conservative P values (Greven et al., 2008) because the mixing 
weight on the 𝜒𝑜
2 component is too low at fifty percent. We have also found 
this to be the case in our setting (Table 1).  
Although one might consider use of a parametric bootstrap to estimate the 
null distribution, e.g., (Greven et al., 2008), such an approach dramatically 
increases the running time over computation of the test statistics themselves 
because of the extremely large number of bootstrap test statistics needed. 
Yet another alternative is to use an empirical distribution based on permu-
tations, which faces a similar problem. However, one can use many fewer 
permutations by instead assuming a parametric form of the null distribution 
and then fitting the few required parameters to the test statistics generated 
from the permutations (Lee, Emond, et al., 2012). It is such an approach 
that we take here. Note that this approach assumes that the null distribution 
of test statistics is the same across all tests, an assumption that has also 
been made in the small sample correction in SKAT-O and elsewhere (Lee, 
Emond, et al., 2012; Greven et al., 2008; Greven, 2007). 
The parametric form of the null distribution that we assume, and to which 
we fit null distribution test statistics to, is inspired by (Greven, 2007; 
Greven et al., 2008), who reported that a mixture of 𝜒𝑜
2 and 𝑎𝜒1
2, where 𝑎 is 
the scaling parameter for the scaled chi-square distribution, yielded good 
type I control when testing a variance component in a single-component 
LMM. We use the same parametric form of the null distribution, except, to 
gain additional flexibility for the two-component LMM, we allow the de-
grees of freedom on the second component, 𝑑, to be different from 1 (find-
ing this to be useful in the sense that we estimate 𝑑 ≠ 1). That is, we use 
the null distribution, 𝜋𝜒𝑜
2: (1 − 𝜋)𝑎𝜒𝑑
2 with free parameters 𝜋, 𝑎, and 𝑑. 
Using this distributional form, we found that a fit of the free parameters to 
the (full collection of test) statistics yielded P values that were too liberal in 
the tail (Table 1). Thus, we instead fit our parametric parameters using only 
the most significant tail of the null distribution of test statistics—in particu-
lar the top 10% of null test statistics. (Note that in our experiments with just 
a single variance component, P values were also liberal in the tail—those 
for which p<<0.05. This regime was not examined by Greven et al.). 
We now describe the details of our approach for estimating the free param-
eters, 𝜋, 𝑎, and 𝑑, of this null distribution. To generate a single null test 
statistic for a set, we permuted the individuals for only the SNPs in that set. 
Because we do not permute the SNPs (rather, the individuals), the pattern 
of linkage disequilibrium between the SNPs within a single test remains 
intact. Although we permute the individuals, who are not (generally) iden-
tically and independently distributed, we do so only for the SNPs in the test 
set, leaving any confounding signal among the covariates, the confounding 
SNPs and the phenotype intact. We found that null distribution parameter 
estimates stabilized with the use of 10 permutations per test (for both 
WTCCC and GAW14). Thus, our procedure has a runtime roughly a factor 
of ten larger than if we had not needed permutations. Within a gene, we use 
the same permutation for all SNPs, and we used the same 10 permutations 
across all sets.  
Given this permutation-generated sample of test statistics from the null 
distribution, we fit the parameters a, and d as follows. The 𝜒𝑜
2 distribu-
tion is a Dirac delta function at 0—that is, this component of the null distri-
bution yields only test statistics of 0, and correspondingly p=1. Further-
more, the 𝜒𝑑>0
2  yields a test statistic of 0 with measure zero. Consequently, 
one can obtain good estimates of the parameters simply by assuming that 
precisely those tests with variance parameter estimate 𝜏 = 0 belong to the 
𝜒𝑜
2 component, and then estimating 𝜋 as the proportion of tests belonging to 
this component. We then estimate 𝑎 and 𝑑 directly from the non-zero test 
statistics (those likely to belong to the 𝑎𝜒𝑑
2 component) using a regression 
in which these parameters are adjusted such that resulting LRT P values 
have the least squared error with the theoretical P values (derived condi-
tionally on an estimate of π). Specifically, we use the log P value squared 
error, and only use the smallest 10% of P values in the regression. This 
truncated regression approach consistently yielded calibrated quantile-
quantile plots (Figure 1) and also controlled type I error (Table 1). Fur-
thermore, it yielded better power than the score test (Table 2).  
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In summary, our overall approach is as follows: (1) for each set to be test-
ed, permute the individuals of the SNPs belonging to this set, all in the 
same manner; (2) compute the restricted LRT statistic for this permuted 
data to obtain a test statistic from the null distribution; (3) repeat step 1 ten 
times; (4) estimate the proportion of test statistics drawn from the 𝜒𝑜
2 com-
ponent, ?̂?, as the proportion of tests in which the parameter τ=0; (5) use the 
largest 10% of test statistics to perform a regression to fit the 𝑎𝜒1
2 compo-
nent —that is find ?̂? and ?̂? which minimize the squared error of the log10 𝑃 
values with their theoretical values (uniform distribution on [?̂?, 1]); (6) 
compute the test statistic for all sets (non-permuted data) and then compute 
the corresponding P values for these using the null distribution ?̂?𝜒𝑜
2: (1 −
?̂?)?̂?𝜒?̂?
2.   
In application to real data (described next), our procedure yielded 𝜋 =
0.641, 𝑎 = 2.29, 𝑑 =0.961, on the GAW14 data, and 𝜋 = 0.643, 𝑎 =
1.41, 𝑑 = 0.85 on the WTCCC data.  
Data Sets and Other Methods 
The first data set was obtained from the Genetic Analysis Workshop 
(GAW) 14 (Edenberg et al., 2005). It consisted of autosomal SNP data 
from an Affymetrix SNP panel and a phenotype indicating whether an 
individual smoked a pack of cigarettes a day or more for six months or 
more. The cohort included over eight ethnicities and numerous close family 
members—1,034 individuals in the dataset had parents, children, or sib-
lings also in the dataset. In addition to the curation provided by GAW, we 
excluded a SNP when either (1) its minor allele frequency was less than 
0.05, (2) its values were missing in more than 10% of the population, or (3) 
its allele frequencies were not in Hardy-Weinberg equilibrium (𝑝 < 0.001). 
In addition, we excluded an individual when more than 10% of SNP values 
were missing. After filtering, there were 7,579 SNPs across 1,261 individu-
als. 
The second data set comprised the Wellcome Trust Case Control Consorti-
um (WTCCC) 1 data and consisted of SNP and phenotype data for seven 
common diseases: bipolar disorder, coronary artery disease, hypertension, 
Crohn's disease, rheumatoid arthritis (RA), type-I diabetes, and type-II 
diabetes (The Wellcome Trust Case Control, 2007). Each phenotype set 
contained about 1,900 individuals. In addition, the data included a set of 
approximately 1,500 controls from the UK Blood Service Control Group 
(NBS). The data did not include a second control group from the 1958 
British Birth Cohort (58C), as restrictions on it precluded use by a com-
mercial organization. Our analysis for the Crohn’s phenotype used data 
from the NBS group and the remaining six phenotypes as controls (Lippert, 
Listgarten, et al., 2013). We filtered SNPs as described by the WTCCC 
(Laaksovirta et al., 2010), and additionally excluded a SNP if either its 
minor-allele frequency was less than 1%, it was missing in greater than 1% 
of individuals, or its genetic distance was unknown. After filtering, 356,441 
SNPs remained. Unlike the approach used by the WTCCC, we included 
non-white individuals and close family members to increase the potential 
for confounding and thereby better exercise the LMM. In total, there were 
14,925 individuals across the seven phenotypes and control, as in our pre-
vious work (Listgarten et al., 2012; Lippert et al., 2011; Lippert, Listgarten, 
et al., 2013). We concentrated our evaluations on Crohn’s disease, as infla-
tion for this phenotype was greatest with an uncorrected univariate analy-
sis. 
For the WTCCC data, we grouped SNPs into gene sets using gene positions 
provided on the USCSC Genome Browser (http://genome.ucsc.edu/) (Kent 
et al., 2002; Dreszer et al., 2012) using build hg19 (we also converted the 
original WTCCC annotations to this build), which yielded 13,850 gene 
sets. Because the GAW14 SNPs mapped to only 251 non-singleton gene 
sets with this strategy, we instead formed sets for this data set by using 
overlapping 1 centimorgan windows, yielding 2,157 sets. For WTCCC, the 
set sizes ranged from 1 to 748, with a mean value of 11, and a standard 
deviation of 24. For the GAW14 data, the set sizes ranged from 2 to 38, 
with a mean value of 5, and a standard deviation of 4. More generally, this 
approach of forming sets from windows of nearby SNPs along the genome 
could be used to map an entire genome into sets, even when the SNPs do 
not lie in genes. However, it is not our goal here to evaluate different ways 
in which one might group SNPs, but instead to demonstrate that we can test 
sets of SNPs in the presence of confounders. 
All analyses assumed additive effects of a SNP on phenotype, using a 0/1/2 
encoding for each SNP (indicating the number of minor alleles for an indi-
vidual). Missing SNP data was mean imputed. Multiple testing was ac-
counted for with a Bonferroni correction. 
In counting hits for Crohn’s disease (Table 4), we omitted any genes found 
in the MHC region because this region is complicated by very long-range 
linkage disequilibrium. We used positions 29-34 Mb on chromosome 6 as 
the boundaries of the MHC, as suggested by the MHC sequencing consor-
tium (Pereyra et al., 2010). 
Experimental Setup to Assess Control of Type I Error and Power 
We used synthetic data based on the real WTCCC data to assess the quality 
of our new method, as well as to compare it against a score test. In particu-
lar, to assess type I error, we used all SNPs from the WTCCC data set, and 
then permuted the individuals for SNPs in each set tested so as to create 
null-only test statistics. We permuted the data in this way a total of 72 
times, yielding 997,200 null test statistics (because 13,850 sets were tested 
for each data set). We additionally permuted another 10 data sets in order to 
estimate the parameters of the null distribution (𝜋, 𝑎, 𝑑) as prescribed by 
our approach. 
For assessment of power, we again used all SNPs from the WTCCC data 
set, and then generated synthetic phenotypes using a linear mixed model. 
To do so, we first we fit the null model to the real data to obtain estimates 
of the parameters 𝜎𝑒
2 and 𝜎𝑔
2. Then we used the model 𝑝(𝒚) =
N(𝒚|𝟎; 𝜎𝑐
2𝑲𝑪 + 𝜎𝑠
2𝑲𝑺]), with confounding variance 𝜎𝑐
2 equal to estimated 
environmental noise, 𝜎𝑒
2 = 0.094, and genetic variance, 𝜎𝑠
2, equal to the 
estimated genetic variance 𝜎𝑔
2 = 0.0125. Furthermore, we used the same 
310 confounding SNPs for 𝑲𝑪 as used on the real data, while using all 
321,839 SNPs further than 2 centimorgans away from those in 𝑲𝑪 as the 
causal SNPs for 𝑲𝑺 (those contained in the true positive sets in our power 
experiments). We generated five phenotypes in this way. The resulting 
phenotypes behaved much like the real data in that, on average, we found 
10 Bonferroni-corrected sets on each of five data sets, as compared to the 
23 found on the real data (note that Table 4 does not include SNPs from the 
MHC region and therefore shows only 16). For both type I error and power 
experiments, we tested the same gene sets as on the real data, except for 
power we did not include any gene sets containing SNPs in the 𝑽𝑪 (those 
SNPs used to correct for confounding) or within 2 centimorgans of these 
SNPs, to be sure that the sets were unambiguously true positives. 
When comparing our LRT approach against a score-based test, we used the 
same score test as SKAT (Wu et al., 2011) which uses the Davies method 
to compute P values from the null distribution (but here with our FaST-
LMM-Set model). This score test has previously been shown to control 
type I error (Lee, Emond, et al., 2012), consistent with our own findings 
(not shown). 
Linear-Time Computations 
What remains left to explain is how to achieve the linear-time speedup in 
the present setting—the case of two random effects. The crux of the cubic 
to linear-time speedup in the single random effect model was to bypass 
construction of 𝑲 and the required spectral decomposition of 𝑲 by recog-
nizing that one can instead use 𝑽 and the spectral decomposition of 𝑽 
(Lippert et al., 2011). Note that we can view the two-random-effects model 
as a single random effect with covariance 𝑲 ≡ (1 − 𝜏)𝑲𝑪 + 𝜏𝑲𝑺. To use 
the algebraic speed-up just mentioned, we observed that 𝑲 = 𝑽𝑽𝑻, where 
now 
 𝑽 ≡ [
𝟏
√𝒔𝒄
𝑽𝑪(1 − 𝜏)
1
2;
𝟏
√𝒔𝒔 
𝑽𝑺𝜏
1
2],   
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using [𝑼; 𝑾] to denote the side-by-side concatenation of matrices 𝑼 and 
𝑾. So long as 𝑠 = 𝑠𝑠 + 𝑠𝑐 < 𝑁, which was true for all of the data sets 
examined here (and almost all others we have analyzed), we obtained the 
linear-time computations and memory footprint just as in Lippert et al. 
(2011). (One might also consider using low rank update equations of the 
type used in Listgarten et al. (2012) to perform exclusion, although we 
have not yet implemented this.) Finally, to perform parameter estimation in 
this two-random-effects model, we used an approach similar to that report-
ed in Lippert et al. (2011). That is, we used a one-dimensional Brent search 
optimization routine to find the value of 𝜏 which maximized the restricted 
likelihood. For each call to the restricted likelihood for a particular value of 
𝜏, efficient computations were performed as in (Lippert et al., 2011), except 
using the two random effects. 
3 RESULTS 
 
Type I Error and Power on Synthetic Data 
First we examined whether our LRT approach controlled type I 
error. As described in Methods, we generated null-only test statis-
tics by way of permutations on the WTCCC data, obtaining a total 
of roughly 1 million test statistics. The type I error was controlled 
(Table 1). Note that neither (1) fitting the null distribution parame-
ters (to all test statistics) by way of maximum likelihood, nor (2) 
use of a 0.5𝜒𝑜
2 ∶ 0.5𝜒1
2 null distribution, yielded calibrated P val-
ues. The first was liberal, while the latter was conservative (Table 
1). Finally, quantile-quantile plots in Figure 1 additionally demon-
strates good calibration over the entire range of P values from our 
method, for the same points as in Table 1. Because the score test 
we used has already been shown to control type I error (Lee, 
Emond, et al., 2012), we do not report on it here, but note that we 
did find the same in our own experiments (not shown). 
Table 1. Type I error estimates for FaST-LMM-Set using one million tests 
across various levels of significance, α.  
Significance Level 
𝛼 = 10−5 𝛼 = 10−4 𝛼 = 10−3 
Fast-LMM-Set 
1 × 10−5 1.21 × 10−4 1.01 × 10−3 
non-truncated ML 
2 × 10−5 * 1.83 × 10−4 * 1.26 × 10−3 * 
0.5𝜒𝑜
2 ∶ 0.5𝜒1
2 
5 × 10−6 4 × 10−5 * 4.55 × 10−4 * 
The first row shows results for our LRT-based method; the second row (“non-
truncated ML”) shows results when fitting the null distribution parameters using 
maximum likelihood with all test statistics; the third row shows results using a 0.5𝜒𝑜
2 ∶
0.5𝜒1
2 null distribution. Results significantly different from expected according to the 
binomial test (p<0.05) are denoted with a *. 
Next we compared the power of our LRT approach to a score test 
approach (both using the same two random effects model) on syn-
thetic data (see Methods). Over five synthetic data sets and a range 
of significance levels, LRT found significantly more sets than the 
score test (Table 2). Furthermore, on the real WTCCC data, LRT 
again found significantly more sets (Table 4). 
 
Fig. 1. Quantile-quantile plot of observed and expected log10 P values on 
the null-only WTCCC data sets (same data as used for Table 1) for FaST-
LMM-Set. Dashed red error bars denote the 99% confidence interval 
around the solid red diagonal. Points shown are for null-only data (generat-
ed by permuting individuals in the SNPs to be tested—see Methods) and 
only for the non-unity P values (those assumed to belong to the non-zero 
degree of freedom component of the null distribution). The portion of the 
expected distribution of P values shown is uniform on the interval [?̂?,1], 
where ?̂? is the estimated mixing weight in the null distribution. 
Table 2. Power experiments.  
𝛼 LRT score P value 
3.6 × 10−6 44 26 0.03 
10−5 60 39 0.03 
10−4 172 138 0.05 
10−3 556 509 0.14 
10−2 2419 2195 0.0009 
 
Number of tests with P values less than α. The last column shows the results of a 
binomial test comparing the number of tests found by LRT as compared to the score 
test. The first row denotes the Bonferroni threshold for the WTCCC data set.   
Application to Real Data 
We investigated our new approach on two data sets. The first was 
the Genetic Analysis Workshop (GAW) 14, which included data 
from over eight ethnicities and numerous close family members for 
a total of 1,261 individuals. After filtering there were 7,579 SNPs 
available for analysis. The second data set was from the WTCCC 
from which we used 14,925 individuals and 356,441 SNPs in our 
analysis. We used the Crohn’s phenotypes because this was the 
one showing the most confounding in an uncorrected analysis. 
Unlike the WTCCC (The Wellcome Trust Case Control, 2007), we 
included non-white data for individuals and close family members 
to increase power and because the LMM can treat them properly 
(Kang et al., 2010; Astle and Balding, 2009; A. Price et al., 2010).  
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To judge the degree of confounding due to genetic relatedness, and 
to ensure that our LMM approach could sufficiently correct for 
confounding, we ran both an uncorrected and corrected univariate 
analysis on each data set, because this is a well-understood test that 
has been reported on before. Here, the extent of test statistic infla-
tion due to unmodelled confounders was assessed using the λ sta-
tistic, also known as the inflation factor from genomic control 
(Devlin and Roeder, 1999). The value λ is defined as the ratio of 
the median observed to median theoretical test statistic. Values of λ 
substantially greater than (less than) 1.0 are indicative of inflation 
(deflation). As can be seen in Table 3, without correction, the test 
statistics appear to be inflated. Although one might consider 𝜆𝐺𝐶 =
1.08 (seen on the corrected analysis of WTCCC) as still moderate-
ly inflated, it has been shown that complex, highly polygenic traits 
lead to increases in 𝜆𝐺𝐶  (Yang et al., 2011) in the absence of spuri-
ous signal. Moreover, the WTCCC themselves reported 𝜆𝐺𝐶  in the 
range of 1.08-1.11 upon removal of individuals from different 
races and related individuals (neither of which we removed), and 
also upon adjustment with two principal components, suggesting 
that a 𝜆𝐺𝐶  of 1.08 is the result of polygenic influence (The 
Wellcome Trust Case Control, 2007).  
Table 3. 𝜆𝐺𝐶 of univariate tests for confounding-corrected and naïve meth-
ods  
Method GAW14 WTCCC 
Uncorrected    
3.80 1.30 
FaST-LMM 1.01 1.08 
 
FaST-LMM denotes a one-component (to correct for confounding) linear mixed 
model, testing one SNP fixed effect (Listgarten et al., 2012); Uncorrected refers to no 
correction for confounding (linear regression).  
 
Having established that both of our data sets required correction 
for confounders and that the LMM with our chosen background 
genetic similarity matrix, 𝑲𝑆, sufficiently corrected for confound-
ers, we next applied FaST-LMM-Set, using the same LMM-
correcting component as in the univariate test. The full set of re-
sults is available for all analyses in Supplemental Table 1. On 
GAW14, the uncorrected set analysis yielded 241 significant sets, 
whereas FaST-LMM-Set, which corrects for confounding, yielded 
none. It is thought that this data set contains little, if any signal (for 
example based on the univariate analysis). On WTCCC Crohn’s 
disease, an uncorrected set analysis yielded 26 significant sets, 
whereas FaST-LMM-Set yielded 16 (Table 4). Next we investigate 
these sets in detail. 
To validate the significant sets recovered on the WTCCC Crohn’s 
phenotype we used a meta-analysis (Franke et al., 2010; Listgarten 
et al., 2012). If a set we found as significant was within 50 
kilobases of a validated SNP/region, we counted it as a true posi-
tive). Additionally, for the genes not validated by the meta-
analysis, we conducted a literature search. Detailed validation re-
sults are provided in Supplemental Table 1. Using our newly de-
veloped method, FaST-LMM-Set, we found 16 significant gene 
sets, of which all but one were validated by the meta-analysis. The 
remaining gene, SLC24A4, performs a similar function to the vali-
dated gene SLC22A4—both are cation transporters 
(www.genecards.org (Rebhan et al., 1997)) —suggesting a promis-
ing candidate for follow-up.  
Table 4. Validation of methods on WTCCC Crohn’s disease  
Method in meta-
analysis 
supported by 
literature 
no support   
found 
FaST-LMM-Set 15 1 0 
FaST-LMM-Set-Score 
7 0 0 
FaST-LMM-Set (uncor-
rected) 
17 3 6 
FaST-LMM-Set denotes our newly developed method which corrects for confounding 
and uses our LRT approach; FaST-LMM-Set (uncorrected) is the same but does not 
correct for confounding with a second variance component; FaST-LMM-Set-Score is 
the same as FaST-LMM-Set but uses a score test (as described in Methods) instead of 
an LRT. Columns: “in meta-analysis” shows the number of significant sets validated 
by a meta-analysis (Franke et al., 2010); “supported by literature” denotes the number 
of significant sets found by a literature search; “no support found” denotes the number 
of sets supported neither by the meta-analysis nor a literature search. 
Advantages of Set Tests over Univariate Tests 
In the course of our analyses we noticed that some sets with small 
P values had almost no univariate signal in any of the SNPs. In 
particular, among the 16 sets in the WTCCC data supported by 
either meta-analysis or literature search, six (C1orf141, SAG, 
SLC24A4, SLC22A4, TCTA, and PTPN2) were missed by the 
univariate analysis (i.e., a SNP lying within 50 kilobases of any of 
the regions reported by Frank et al. was not found to be signifi-
cant). One of the motivations for doing set analysis is to uncover 
signals for such regions. The intuition here is the same as in a uni-
variate conditional GWAS analysis. That is, conditioning on varia-
bles can lead to an increase in power, revealing signal that would 
be hidden without the conditioning (Atwell et al., 2010; Segura et 
al., 2012). Thus the set test acts not only to aggregate weak signal, 
but also to unmask signal hidden by covariates included by virtue 
of doing a set test. We investigated one such case in detail. In par-
ticular, we computed the univariate P values for each of the 15 
SNPs associated with the gene SLC22A4, marginally, as well as 
conditioned on all the other SNPs in this gene, using a LMM to 
correct for confounding. This gene was found to be associated with 
Crohn’s disease using FaST-LMM-Set with 𝑝 = 7.6 × 10−8. The 
smallest marginal univariate P value was 1.2 × 10−5, but when we 
conditioned on the other SNPs in the set, the smallest conditional 
univariate P value obtained was 7.0 × 10−8. This result demon-
strates the increased power afforded by the set test owing to the 
interplay of SNPs within the gene that is missed by a univariate 
approach. 
 
Significance of Sets is Independent of Set Size 
 
On data with phenotypic association, we expected that there could 
be correlation between set size and P value, because with a larger 
set, there could be more predictive SNPs and more power. Fur-
thermore, we expected that when confounders were not properly 
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accounted for in the set analysis, that the more SNPs in a set, the 
more power the set would have to detect these confounders, and 
therefore the stronger the correlation between set size and P value 
would appear. The correlations on our real data were consistent 
with these expectations.  In particular, we saw no significant corre-
lation for FaST-LMM-Set (which corrects for confounders) but 
significant correlation when we did not correct for confounders 
(Table 5).  
We also expected that on null-only data, when confounders were 
properly accounted for, the set P value and set size would be inde-
pendent.  Consistent with this expectation, when we permuted the 
Crohn’s phenotype to remove signal, the FaST-LMM-Set correla-
tion was reduced to 𝜌 = 0.019 (𝑝 = 0.18). 
Table 5. Pearson correlation of log10(P) values with set size.  
Method FaST-LMM-Set (uncor-
rected) 
 FaST-LMM-Set 
 GAW14 0.27 (𝟐 × 𝟏𝟎−𝟑𝟒) 0.001 (0.98) 
 WTCCC 0.051 (𝟑 × 𝟏𝟎−𝟓) 0.025 (0.06) 
 
FaST-LMM-Set denotes our newly developed method; FaST-LMM-Set (uncorrected) 
is the same but does not correct for confounding with a second variance component. 
The P value is reported in parentheses next to the value for 𝜌. Significant entries are 
bolded. We excluded P values from the zero degree-of-freedom component of our 
one-sided test, as their inclusion would violate the assumptions of the Pearson correla-
tion test.  
4 DISCUSSION 
We have developed a novel, efficient approach for testing sets of 
genetic markers in the presence of confounding structure such as 
arises from ethnic diversity and family relatedness within a cohort. 
Application of this algorithm demonstrated that our method cor-
rects for confounders and uncovers signal not recoverable by uni-
variate analysis. 
Although we did not analyse rare variant data, we have shown 
elsewhere that the underlying LMM methodology works well to 
correct for confounding due to rare variants in a univariate setting 
(Listgarten et al., 2013). Furthermore, others have already shown 
that LMM-based set tests work well for detection of sets of associ-
ated rare variants (Wu et al., 2011). It follows that the hybrid ap-
proach that we presented here is likely to prove effective in the 
setting of testing sets of rare variants in the presence of confound-
ers, although this remains to be investigated fully. For example, we 
have found the use of a linear model on a case-control phenotype 
to yield inflated tests statistics when testing rare variants. 
We have demonstrated that our LRT outperforms a score test for 
our model and setting. This is perhaps unsurprising given that the 
score test can be viewed as an approximation to the LRT by a sec-
ond-order Taylor series expansion (Buse, 2007) in the neighbour-
hood of the null model. Furthermore, given its robust properties, 
the LRT is considered the benchmark for statistical testing 
(Crainiceanu, 2008). We note, however, that in some recent work 
(D.-Y. Lin and Z.-Z. Tang, 2011), when testing for rare variants 
using a logistic fixed effects model, a score test was found to per-
form better than LRT, which was found to be liberal. Although the 
best test may depend on context, we note that Lin et al. used a 
different model than we did and, in particular, did not use a vari-
ance component approach. Also, they used closed-form, asymptot-
ic-based LRT P values rather than making use of empirically-
derived null distributions as we have done here. 
For many cases of hidden structure in genetic data, the use of prin-
cipal component-based covariates is sufficient for correction (A. L. 
Price et al., 2006), and thus these covariates could immediately be 
added to existing models such as SKAT (Wu et al., 2011) to 
achieve a set test that corrects for confounding. However, it is now 
widely accepted that there are various forms of confounders which 
cannot be corrected for by principal components, but for which a 
LMM adequately corrects (Kang et al., 2010; Yu et al., 2006; A. 
Price et al., 2010), and it is for these problems that we have devel-
oped our approach. 
 
  
We here focused on testing SNPs in a manner similar to SKAT 
(Wu et al., 2011). However, it would be straightforward to also 
adapt FaST-LMM-Set to the approach of SKAT-O, in which the 
original SKAT model is in effect combined with a collapsing-type 
approach (Lee, Emond, et al., 2012; Lee, Wu, et al., 2012). 
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